Get to Know OxyPrem
Get to Know OxyPrem
OxyPrem has exceeded its goal of €2,300,000, reaching 114.8% of its campaign target. Notable investors include Esperanto Capital—a family office specializing in healthcare—and Swiss entrepreneur Urs Tschudin.
Although their funding round is nearing its close, Oxyprem is hosting a final exclusive meeting for doctors, investors, and healthcare enthusiasts eager to learn how Oxyprem is changing respiratory care.
Explore the details here: https://capitalcell.com/en/campaign/oxyprem/
What will we cover in these sessions?
What is OxyPrem?
Discover the team behind OxyPrem, their mission, current progress, and future plans.
Why is this project so relevant?
Learn about the unique value proposition of OxyPrem and the impact it aims to have on patient care.
Q&A Session
Get answers to your questions about Capital Cell, how it works, and how you can be part of this journey.
Spread the Word
Share this webinar with your network to help deliver innovative healthcare solutions to millions of premature babies worldwide.
See you soon!